(Q45910166)

17 December 2017

title

EGFR-directed treatments in SCCHN. (English)

1 reference

17 December 2017

1

Everett E Vokes

1 reference

17 December 2017

2

Tanguy Y Seiwert

1 reference

17 December 2017

publication date

6 June 2013

1 reference

17 December 2017

Lancet Oncology Commission

published in

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

672-673

1 reference

17 December 2017

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970215-8

7 January 2021

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970215-8

7 January 2021

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970215-8

7 January 2021

Biomarkers of HPV infection in oropharyngeal carcinomas: can we find simplicity in the puzzle of complexity?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970215-8

7 January 2021

Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970215-8

7 January 2021

Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970215-8

7 January 2021

10.1016/S1470-2045(13)70215-8

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017